Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q2 2019 · 10-Q
Revenue$0.00$0.00derivedno prior Q2 2018 on file Net Income-$2.46M-$2.46MN/M vs Q2 2018 EPS Diluted-$0.61-$0.61N/M vs Q2 2018 Operating Income-$2,988,417N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,806,536N/M ended Jun 30, 2019 · filed Aug 7, 2019 · 38 d after period end